Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder

A drug from Celgene and Acceleron Pharma has met the main goals of a late-stage test as a treatment for a rare blood disorder, the second set of positive results that the partners have released for th…
Read the full story: Xconomy